COVID-19-related Death (n 180)*
aOR (95CI) p
SARS-CoV-2 Ct 0.84 (0.72-0.97) 0.023
Age 1.25 (1.11-1.40) <0.01
Sex 1.26 (0.21-7.55) 0.80
Time from COVID-19 onset to diagnostic swab 1.03 (0.91-1.18) 0.63
Number of comorbidities 2.44 (1.18-5.04) 0.016
Worst oxygen support None
Low-flow wall oxygen-reservoir
CPAP
Intubation
- 2.01 (0.14-8.98) 2.14 (0.65-7.01) 2.38 (0.94-6.06) - 0.61 0.34 0.068
COVID-19 Severity (n 180)* COVID-19 Severity (n 180)* COVID-19 Severity (n 180)*
aOR (95CI) P
SARS-CoV-2 Ct 0.95 (0.91-0.99) 0.023
Age 1.08 (1.06-1.11) <0.01
Sex 0.31 (0.17-0.58) <0.01
Time from COVID-19 onset to diagnostic swab 1.04 (0.98-1.11) 0.21
Number of comorbidities 1.6 (1.29-2.03) <0.01
Number of signs and symptoms at diagnosis (n 180)* Number of signs and symptoms at diagnosis (n 180)* Number of signs and symptoms at diagnosis (n 180)*
β (95CI) P
SARS-CoV-2 Ct -0.060 (-0.10; -0.018) <0.01
Age -0.013 (-0.32; 0.006) 0.17
Sex -0.12 (-0.69; 0.44) 0.67
Number of comorbidities 0.24 (-0.013; 0.50) 0.063
Time from COVID-19 onset to diagnostic swab -0.12 (-0.62; 0.51) 0.99
6-month sequelae in survivors (n 149)* 6-month sequelae in survivors (n 149)* 6-month sequelae in survivors (n 149)*
aOR (95CI) P
SARS-CoV-2 Ct 0.90 (0.85-0.96) <0.01
Age 1.02 (0.98-1.04) 0.30
Sex 0.59 (0.26-1.35) 0.21
Time from COVID-19 onset to diagnostic swab 0.98 (0.89-1.07) 0.63
Number of comorbidities 1.01 (0.68-1.48) 0.97
Worst oxygen support None
Low-flow wall oxygen-reservoir
CPAP
Intubation
- 1.02 (0.37-2.82) 1.27 (0.37-4.38) 1.72 (0.41-7.29) - 0.97 0.71 0.46